A recent comprehensive study by Mercer reveals a significant shift in employer-sponsored healthcare, with nearly half (48%) of large U.S. employers – those with 500 or more employees – anticipating making changes to their medical plans that will directly increase out-of-pocket costs for employees in the upcoming year. These adjustments are expected to manifest through various mechanisms, including elevated deductibles and co-pays, as companies grapple with the relentless ascent of health benefit expenditures. The findings underscore a critical juncture where employers must balance the imperative of cost management with the profound importance of healthcare affordability for their workforce.
The Economic Imperative Driving Cost-Sharing
The decision by a substantial segment of the nation’s large employers to pass on a greater share of healthcare costs to employees is a direct response to what Mercer describes as "intense pressure to manage another year of elevated health benefit cost growth." Simon Camaj, Mercer’s U.S. health leader, articulated this dilemma, stating, "Employers are under intense pressure to manage another year of elevated health benefit cost growth, but they also know that affordability matters deeply to employees." This sentiment highlights the delicate balancing act faced by organizations striving to maintain competitive benefits while confronting an environment of persistent inflation and burgeoning medical expenses.
The projected increases for 2027 are not isolated incidents but rather a continuation of a multi-year trend. Overall health benefit costs are forecast to surge by 6.7% in 2026, pushing the average cost per employee above an unprecedented $18,500. This upward trajectory reflects a complex interplay of factors, including the aging U.S. population, the increasing prevalence of chronic conditions, advancements in medical technology, and the rising costs of specialized treatments and prescription drugs. For employers, these figures translate into substantial line-item expenses that directly impact their operational budgets and profitability.
Navigating the Prescription Drug Landscape: The GLP-1 Conundrum
A primary driver of these escalating costs remains prescription drugs, with expenses in this category alone projected to climb by approximately 9% in 2026. This segment of healthcare spending has been particularly volatile, influenced by the introduction of groundbreaking but costly specialty medications, gene therapies, and, notably, GLP-1 medications. These drugs, originally developed for diabetes management, have seen a rapid expansion in their use for weight loss, creating both therapeutic opportunities and significant financial challenges for plan sponsors.
The trajectory of GLP-1 medication coverage illustrates the dynamic nature of employer benefit strategies. While coverage for GLP-1 medications for weight loss surged, reaching 49% of large employers last year, Mercer’s latest survey indicates a notable reversal. In 2026, 6% of large employers are dropping coverage for these drugs, with an additional 5% planning to cease coverage in 2027. Furthermore, 27% of employers either tightened utilization controls this year or intend to do so next year. This shift reflects mounting concern over the long-term budgetary impact of these highly effective but expensive medications.
Alysha Fluno, Mercer’s U.S. pharmacy practice leader, commented on the broader implications of these trends: "The pressure created by specialist drugs, gene therapies and GLP-1 medications is forcing employers to take a much harder look at their pharmacy strategies." She emphasized that the priority has shifted beyond mere utilization management to a demand for greater transparency, control, and assurance that "every dollar spent is delivering maximum value." The average annual cost for GLP-1 medications can range from $10,000 to $15,000 per patient, posing a substantial financial burden if broad coverage is maintained without stringent controls, especially given the high prevalence of obesity and related conditions in the U.S. population.
The rising cost of prescription drugs has also caught the attention of policymakers. A proposed bill, for instance, seeks to mandate that insurers count all prescription drug purchases toward a patient’s deductible, irrespective of whether the drug is covered by the plan’s formulary. Such legislative efforts underscore a growing societal recognition of the need to address drug pricing and access, creating an additional layer of complexity for employers as they design their benefit packages.
Exploring Alternative Plan Designs and Value-Based Care
Beyond traditional cost-sharing tactics, employers are actively exploring innovative approaches to manage healthcare expenditures without solely burdening employees. A significant portion of large employers is moving towards alternative, lower-cost plan designs. By 2027, 31% of large employers anticipate offering or planning non-traditional medical plans, with another 38% actively considering them. These plans often feature reduced cost-sharing for members who utilize high-performing provider networks.
These "non-traditional" models typically emphasize value-based care, where healthcare providers are reimbursed based on patient outcomes rather than the volume of services rendered. This approach encourages greater coordination among providers, preventive care, and the efficient use of resources. For employees, this can translate into lower out-of-pocket costs when they choose providers within these curated networks, fostering a shift towards more efficient and effective care pathways. This strategy represents a proactive effort by employers to guide their workforce towards higher-value care, aiming to improve health outcomes while simultaneously containing costs.
Investment in High-Value Benefits: A Dual Strategy
Despite the pressures to increase employee cost-sharing, the Mercer study also highlights a parallel trend: large employers are significantly investing in high-value benefits that support critical aspects of employee well-being, particularly family building and caregiving. This dual strategy reflects an understanding that while cost management is essential, competitive benefits are equally crucial for attracting and retaining top talent in a tight labor market.
Family-building benefits, once considered niche, are becoming mainstream. IVF coverage is now offered by 50% of all large employers, a figure that jumps to 77% for organizations with 20,000 or more employees. This expansion acknowledges the evolving demographics of the workforce and the increasing demand for support in family formation. Complementing this, many organizations also provide financial assistance for adoption (46%) and surrogacy (25%), recognizing diverse paths to parenthood. These benefits are not merely perks; they are increasingly seen as fundamental components of a supportive work environment that addresses the holistic needs of employees.
Caregiving support is another area of heightened employer focus. More than half of large employers offer childcare resources (51%), and a substantial 58% provide eldercare benefits. These initiatives are designed to help employees manage the often-overwhelming responsibilities of caring for dependents, whether young children or aging parents. By alleviating some of these burdens, employers aim to reduce employee stress, improve work-life balance, and ultimately enhance productivity and retention.
Addressing Financial Strain and Mental Well-being
The Mercer survey also identified financial strain as the top concern for U.S. employees amidst the backdrop of rising living and healthcare costs. Employers are responding to this critical need by expanding various forms of support. This includes increased access to financial counseling, debt management resources, and robust mental health support services. The interconnectedness of financial stability and mental well-being is increasingly recognized, with financial worries often contributing to stress, anxiety, and depression. Providing resources in these areas not only addresses immediate employee needs but also contributes to a healthier, more engaged workforce. Some organizations are even extending limited relief for employees impacted by extreme weather events, demonstrating a broader commitment to employee resilience in the face of unforeseen challenges.
This strategic investment in high-value benefits, alongside necessary cost-sharing adjustments, reflects a sophisticated approach to total rewards. Employers are acknowledging that while some financial shifts are unavoidable in healthcare, they must simultaneously fortify other areas of support to maintain employee morale, productivity, and loyalty. An HR executive from a national retail chain, speaking on background, noted, "It’s about finding equilibrium. We have to be fiscally responsible, but we also know that our people are our greatest asset. Investing in their family well-being, mental health, and financial security is not just good for them; it’s good for our business."
Chronology and Future Outlook
The trajectory of these changes can be traced over the past several years, with escalating healthcare costs becoming a persistent concern for employers. The 2026 and 2027 projections from Mercer highlight a critical inflection point, where previous strategies are being re-evaluated and new approaches are gaining traction.
- Pre-2023: Gradual increase in healthcare costs, with employers often absorbing a larger share or making incremental adjustments.
- 2023-2024: Post-pandemic surge in healthcare utilization and inflation begins to exert significant pressure. Rapid adoption of GLP-1 medications begins.
- 2025: Initial projections for 2026 emerge, signaling continued high growth in costs. Early discussions about GLP-1 cost management intensify.
- 2026: Projected 6.7% overall health benefit cost increase and 9% prescription drug cost increase. 6% of large employers drop GLP-1 coverage, 27% tighten controls.
- 2027: 48% of large employers anticipate increasing employee out-of-pocket costs. Another 5% plan to drop GLP-1 coverage. 31% will offer non-traditional medical plans, with 38% considering them.
Looking ahead, the landscape of employer-sponsored healthcare is likely to continue evolving rapidly. The push towards value-based care models, greater transparency in drug pricing, and personalized benefit offerings will intensify. Technology will play an increasingly vital role in helping employees navigate complex benefit choices, access care efficiently, and manage their health proactively. The ongoing dialogue between employers, employees, providers, and policymakers will shape how healthcare is delivered and financed in the coming decade, with an enduring focus on balancing access, quality, and affordability. The imperative for employers will remain multifaceted: to manage costs effectively while simultaneously cultivating a supportive and competitive environment that prioritizes the holistic well-being of their workforce.
